Neuroimaging science has seen a recent explosion in dataset size driving the need to develop database management with efficient processing pipelines. Multi-center neuroimaging databases consistently receive magnetic resonance imaging (MRI) data with unlabeled or incorrectly labeled contrast. There is a need to automatically identify the contrast of MRI scans to save database-managing facilities valuable resources spent by trained technicians required for visual inspection. We developed a deep learning (DL) algorithm with convolution neural network architecture to automatically infer the contrast of MRI scans based on the image intensity of multiple slices. For comparison, we developed a random forest (RF) algorithm to automatically infer the contrast of MRI scans based on acquisition parameters. The DL algorithm was able to automatically identify the MRI contrast of an unseen dataset with <0.2% error rate. The RF algorithm was able to identify the MRI contrast of the same dataset with 1.74% error rate. Our analysis showed that reduced dataset sizes caused the DL algorithm to lose generalizability. Finally, we developed a confidence measure, which made it possible to detect, with 100% specificity, all MRI volumes that were misclassified by the DL algorithm. This confidence measure can be used to alert the user on the need to inspect the small fraction of MRI volumes that are prone to misclassification. Our study introduces a practical solution for automatically identifying the MRI contrast. Furthermore, it demonstrates the powerful combination of convolution neural networks and DL for analyzing large MRI datasets.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s12021-018-9387-8 | DOI Listing |
Alzheimers Dement
December 2024
Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Background: Alzheimer's disease (AD) is a significant health concern affecting at least 10% of individuals aged 65 and older, with heightened risk in Black and Hispanic/Latino populations. Despite this prevalence, our analysis of University of California Los Angeles (UCLA) electronic health records (EHR) indicates that only 4% of patients aged 65 or older receive an AD diagnosis, with underdiagnosis more prevalent among Black and Hispanic/Latino patients compared to their white counterparts. To address this issue, we propose implementing a concise dementia screening tool (DST) in real-world clinical settings.
View Article and Find Full Text PDFIntroduction: Evaluation of functional dependence in activities of daily living (ADLs) and instrumental activities of daily living (iADLs) is necessary for dementia diagnosis. ADL and iADL questionnaires are typically employed, but with progressive cognitive impairment, a care partner must step in to assist with these tests, causing logistical burdens. Pre-screening tools that triage patients in need of formal functional assessment would optimize clinical workflows.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Department of Neurology, Harvard Medical School, Boston, MA, USA.
Background: Semantic memory refers to knowledge of attributes associated with common objects. Quantifying the strength of semantic association between successive 'animal' fluency responses can be challenging. The current research assessed between-group differences for 'animal' fluency total output and selected verbal serial list learning, episodic memory measures.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
ki:elements GmbH, Saarbrücken, Germany.
Background: Changes in speech and language functions have shown to be early symptoms of AD pathology. Recent developments in automatic speech and language processing have opened avenues for objective assessments of these changes. The primary objective of this study is to explore whether speech and language markers extracted from cognitive testing conducted during an automated phone call differ according to underlying AD pathology as measured in cerebrospinal fluid (CSF) in preclinical or early stage individuals.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Department of Neurology, Harvard Medical School, Boston, MA, USA.
Background: There is an urgent need for neuropsychological screening tests that are easily deployed and reliable. We have developed a digital neuropsychological screening protocol that is administered on a tablet, automatically scored using artificial intelligence, and requires approximately 10 minutes to administer. This tablet-administered protocol assesses the requisite neurocognitive constructs associated with emergent neurodegenerative illness METHOD: The digital protocol was administered to 77 ambulatory care/ memory clinic patients (Table1).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!